{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:48:40Z","timestamp":1782200920534,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.transci.2026.104375","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T16:29:08Z","timestamp":1768580948000},"page":"104375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical study of recombinant human thrombopoietin in platelet engraftment following autologous hematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"65","author":[{"given":"Shunsen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5291-1655","authenticated-orcid":false,"given":"Jian","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.transci.2026.104375_bib1","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41409-024-02419-8","article-title":"Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group","volume":"59","author":"Xu","year":"2024","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"10.1016\/j.transci.2026.104375_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040863","article-title":"Role of stem cell transplantation in multiple myeloma","volume":"13","author":"Devarakonda","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.transci.2026.104375_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.27746","article-title":"Efficacy and safety of hetrombopag versus thrombopoietin in promoting platelet engraftment after allogeneic hematopoietic stem cell transplantation: a prospective, multicenter, randomized controlled clinical trial","author":"Feng","year":"2025","journal-title":"Am J Hematol"},{"issue":"21","key":"10.1016\/j.transci.2026.104375_bib4","doi-asserted-by":"crossref","first-page":"7641","DOI":"10.1002\/cam4.4294","article-title":"Recombinant human thrombopoietin improved platelet engraftment after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma","volume":"10","author":"Gu","year":"2021","journal-title":"Cancer Med"},{"issue":"11","key":"10.1016\/j.transci.2026.104375_bib5","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1182\/blood-2006-10-019315","article-title":"New thrombopoietic growth factors","volume":"109","author":"Kuter","year":"2007","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.transci.2026.104375_bib6","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.exphem.2009.09.001","article-title":"Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL","volume":"37","author":"Nishino","year":"2009","journal-title":"Exp Hematol"},{"issue":"1","key":"10.1016\/j.transci.2026.104375_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2141.1996.4761013.x","article-title":"Effects of recombinant human thrombopoietin on megakaryocyte colony formation and megakaryocyte ploidy by human CD34+ cells in a serum-free system","volume":"93","author":"Angchaisuksiri","year":"1996","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.transci.2026.104375_bib8","article-title":"Effect and safety of recombinant human thrombopoietin on haematopoietic reconstitution after allogeneic haematopoietic cell transplantation","volume":"73","author":"Tian","year":"2025","journal-title":"Curr Res Transl Med"},{"issue":"7","key":"10.1016\/j.transci.2026.104375_bib9","doi-asserted-by":"crossref","DOI":"10.4252\/wjsc.v17.i7.106579","article-title":"Recombinant human thrombopoietin safety and efficacy in pediatric allogeneic hematopoietic stem cell transplantation: a cohort study","volume":"17","author":"Li","year":"2025","journal-title":"World J Stem Cells"},{"issue":"5","key":"10.1016\/j.transci.2026.104375_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2024.103972","article-title":"Recombinant human thrombopoietin improves platelet engraftment after autologous hematopoietic stem cell transplantation in patients with aggressive lymphoma","volume":"63","author":"Qiu","year":"2024","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"10.1016\/j.transci.2026.104375_bib11","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1038\/s41598-025-89535-7","article-title":"Recombinant human thrombopoietin does not promote platelet engraftment in newly diagnosed multiple myeloma patients following autologous stem cell transplantation","volume":"15","author":"Wang","year":"2025","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.transci.2026.104375_bib12","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1182\/bloodadvances.2022007838","article-title":"Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantation","volume":"7","author":"Scordo","year":"2023","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.transci.2026.104375_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2022.103482","article-title":"The effect of G-CSF used after allogeneic hematopoietic stem cell transplantation on engraftment times and platelet suspension replacement numbers","volume":"61","author":"Sar\u0131c\u0131","year":"2022","journal-title":"Transfus Apher Sci"},{"issue":"11","key":"10.1016\/j.transci.2026.104375_bib14","first-page":"696.e1","article-title":"Revisiting the utility of granulocyte colony-stimulating factor post-autologous hematopoietic stem cell transplantation for outpatient-based transplantations","volume":"29","author":"Portuguese","year":"2023","journal-title":"Transpl Cell Ther"},{"issue":"5","key":"10.1016\/j.transci.2026.104375_bib15","first-page":"500","article-title":"Recombinant human thrombopoietin promotes platelet engraftment in severe aplastic anemia patients following treatment with haploid hematopoietic stem cell transplantation using modified post-transplantation cyclophosphamide","volume":"30","author":"Fu","year":"2024","journal-title":"Transpl Cell Ther"},{"issue":"2","key":"10.1016\/j.transci.2026.104375_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/bjh.12772","article-title":"Thrombopoietin from beginning to end","volume":"165","author":"Hitchcock","year":"2014","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.transci.2026.104375_bib17","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1182\/blood.V88.9.3363.bloodjournal8893363","article-title":"Synergistic effects of thrombopoietin and granulocyte colony-stimulating factor on neutrophil recovery in myelosuppressed mice","volume":"88","author":"Grossmann","year":"1996","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.transci.2026.104375_bib18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00277-003-0729-7","article-title":"Thrombopoietin stimulates ex vivo expansion of mature neutrophils in the early stages of differentiation","volume":"82","author":"Terada","year":"2003","journal-title":"Ann Hematol"},{"issue":"12","key":"10.1016\/j.transci.2026.104375_bib19","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1007\/s00277-020-04112-4","article-title":"Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma","volume":"99","author":"Nagayama","year":"2020","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.transci.2026.104375_bib20","first-page":"517","article-title":"Subsets of CD34+ hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation","volume":"84","author":"Meldgaard Knudsen","year":"1999","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.transci.2026.104375_bib21","doi-asserted-by":"crossref","first-page":"S291","DOI":"10.1016\/j.htct.2024.09.2481","article-title":"Predictive factors for engraftment kinetics of autologous hematopoietic stem cells in children","volume":"46 6","author":"Andri\u0107","year":"2024","journal-title":"Hematol Transfus Cell Ther"},{"issue":"6","key":"10.1016\/j.transci.2026.104375_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2023.103830","article-title":"Overview on novel strategies and current guidelines for hematopoietic stem cell mobilisation and collection","volume":"62","author":"Lanza","year":"2023","journal-title":"Transfus Apher Sci"},{"issue":"12","key":"10.1016\/j.transci.2026.104375_bib23","first-page":"979","article-title":"Consensus of Chinese experts on the mobilization and collection of autologous hematopoietic stem cells in lymphoma (2020)","volume":"41","author":"Chinese Society of Hematology, C.M.A","year":"2020","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"10","key":"10.1016\/j.transci.2026.104375_bib24","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1182\/blood-2015-08-607929","article-title":"Understanding platelet generation from megakaryocytes: implications for in vitro-derived platelets","volume":"127","author":"Sim","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.transci.2026.104375_bib25","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s12032-011-0029-3","article-title":"Autologous hematopoietic stem cell transplantation in multiple myeloma and lymphoma: an analysis of factors influencing stem cell collection and hematological recovery","volume":"29","author":"Ungerstedt","year":"2012","journal-title":"Med Oncol"},{"issue":"7","key":"10.1016\/j.transci.2026.104375_bib26","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/bmt.2014.39","article-title":"Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation","volume":"49","author":"Mohty","year":"2014","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"10.1016\/j.transci.2026.104375_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030608","article-title":"Poor mobilizers in lymphoma but not myeloma patients had significantly poorer progression-free survival after autologous stem cell transplantation: results of a large retrospective, single-center observational study","volume":"15","author":"Steiner","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.transci.2026.104375_bib28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/vox.12183","article-title":"Incidence and risk factors of poor mobilization in adult autologous peripheral blood stem cell transplantation: a single-centre experience","volume":"107","author":"Lee","year":"2014","journal-title":"Vox Sang"},{"issue":"6","key":"10.1016\/j.transci.2026.104375_bib29","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-2141.2005.05529.x","article-title":"Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study","volume":"129","author":"Cortelezzi","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2026.104375_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.critrevonc.2016.09.004","article-title":"An overview of hematopoietic stem cell transplantation related thrombotic complications","volume":"107","author":"Sahin","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.transci.2026.104375_bib31","article-title":"Comparative efficacy and safety of rhTPO, romiplostim, and eltrombopag in the treatment of pediatric primary immune thrombocytopenia: a systematic review and network meta-analysis","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.transci.2026.104375_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1657169","article-title":"Efficacy and safety of different treatments in chemotherapy-induced thrombocytopenia: a systematic review and network meta-analysis","volume":"16","author":"Yang","year":"2025","journal-title":"Front Pharmacol"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226000078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226000078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:17:14Z","timestamp":1782199034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050226000078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1473050226000078"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2026.104375","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical study of recombinant human thrombopoietin in platelet engraftment following autologous hematopoietic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2026.104375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104375"}}